Equities research analysts expect that PTC Therapeutics, Inc. (NASDAQ:PTCT) will announce $96.21 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for PTC Therapeutics’ earnings, with estimates ranging from $84.80 million to $119.10 million. PTC Therapeutics posted sales of $68.26 million during the same quarter last year, which […]
